Arasani, Norhelen E.

HRN: 21-37-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2022
CEFUROXIME 750MG (VIAL)
05/11/2022
05/17/2022
IV
750mg
Q8H
UTI, Ascariasis

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Guideline Not Available